Review
Biochemistry & Molecular Biology
Lili Liang, Andreas M. Kaufmann
Summary: Cancer stem cells (CSCs) have been identified and characterized in both hematopoietic and solid tumors. They possess unique properties, including slow proliferation, self-renewal, differentiation, and the ability to undergo epithelial-mesenchymal transition (EMT) and its reverse process. CSCs play a crucial role in tumor growth, therapy resistance, and cancer metastasis. Strategies targeting CSCs are being developed for novel anti-metastasis treatments, aiming to improve therapeutic efficiency and prognosis with fewer side effects.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Oncology
Xiaosu Chen, Yajing Lv, Kejia Xu, Xiaoshuang Wang, Yujia Zhao, Jia Li, Xuan Qin, Yi Shi, Longlong Wang, Antao Chang, Chongbiao Huang, Rong Xiang
Summary: Chemotherapeutic agents, including cisplatin, have been shown to promote tumor metastasis by influencing the stability of beta-catenin through the key gene DCBLD2. The inhibition of DCBLD2 presents a promising treatment option for preventing chemotherapy-induced metastasis.
Article
Oncology
Jian Yang, Gaomeng Luo, Chang Li, Zhunlin Zhao, Sheng Ju, Qifan Li, Zhike Chen, Cheng Ding, Xin Tong, Jun Zhao
Summary: Through comprehensive bioinformatics analysis, we found that CST1 may be a novel prognostic biomarker in LUAD and promotes epithelial-mesenchymal transition in LUAD cells.
Article
Oncology
Mitsunobu Oba, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, Katsunori Sasaki, Kanako C. Hatanaka, Masako Sasaki, Ayae Nange, Asami Okumura, Mariko Hayashi, Yusuke Yoshida, Takeo Nitta, Takashi Ueno, Toru Yamada, Masato Ono, Shota Kuwabara, Keisuke Okamura, Takahiro Tsuchikawa, Toru Nakamura, Takehiro Noji, Toshimichi Asano, Kimitaka Tanaka, Kiyoshi Takayama, Yutaka Hatanaka, Satoshi Hirano
Summary: This study examined the association between CCR7 expression and clinicopathological features and EMT in EHCC. High-grade CCR7 expression was significantly correlated with aggressive tumor characteristics, low E-cadherin expression, and poor overall survival. Further experiments demonstrated that CCR7 promotes EHCC cell invasion and migration through induction of EMT, which can be inhibited by a CCR7 antagonist. These findings suggest that CCR7 may serve as a potential target for adjuvant therapy in EHCC.
Article
Oncology
Meredith S. Brown, Kristen E. Muller, Diwakar R. Pattabiraman
Summary: The epithelial-to-mesenchymal transition (EMT) and its reversal, the mesenchymal-to-epithelial transition (MET), play critical roles in the metastasis of breast cancer and other solid tumors. However, defining and quantifying EMT status is not commonly used in clinical practice. Therefore, identifying and measuring the presence of different EMT states in tumors is a crucial first step in evaluating patient prognosis.
Article
Pharmacology & Pharmacy
Hongchao Zhang, Guopei Zhang, Jingyue Zhang, Mingyang Xiao, Su Cui, Shengwen Wu, Cuihong Jin, Jinghua Yang, Xiaobo Lu
Summary: Tobacco, specifically nicotine, plays a significant role in the development and progression of lung cancer through the induction of epithelial-mesenchymal transition (EMT). This study reveals the interplay between PPP1R13L and SP1 in nicotine-induced EMT, showing that PPP1R13L inhibits the transcriptional activity of SP1 while also being transcriptionally activated by SP1 in a feedback loop. The expression of PPP1R13L and SP1 is associated with the clinicopathological characteristics of lung cancer patients.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Medicine, Research & Experimental
Ning Zhao, Minwei He, Wei Chen, Peng Jin, Lulu Cao, Jinhai Deng, Xu Cheng, Lu Wang
Summary: Our study identified FAM96A as a crucial regulator of tumor metastasis and epithelial-mesenchymal transition (EMT) by inhibiting the TGF-beta signaling pathway.
Article
Oncology
Yujing Sun, Junyi He, Duan-Bo Shi, Hui Zhang, Xu Chen, Ai-Yan Xing, Peng Gao
Summary: TB can predict lymph node metastasis and is negatively associated with overall survival of patients. Higher ZBTB7A expression in the tumor margin may contribute to the dissociation of tumor cells from the tumor mass to form TB by initiating EMT via EGFR-MEK-ERK and PI3K-AKT-mTOR pathway.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2021)
Article
Oncology
Marie-Lucie Racu, Laetitia Lebrun, Andrea Alex Schiavo, Claude Van Campenhout, Sarah De Clercq, Lara Absil, Esmeralda Minguijon Perez, Calliope Maris, Christine Decaestecker, Isabelle Salmon, Nicky D'Haene
Summary: Pancreatic ductal adenocarcinoma (PDAC) has a low survival rate and its incidence is increasing over time. Understanding the molecular mechanisms behind metastasis and chemoresistance in PDAC is crucial, as these are the main causes of death in patients. SMAD4 is deactivated in half of PDAC cases and its loss is associated with worse overall survival and metastasis. SMAD4 is a key transducer in the TGF-beta pathway, which plays a role in epithelial-mesenchymal transition (EMT). EMT is a biological process where epithelial cells lose their characteristics and acquire a more mesenchymal phenotype, leading to increased motility. Recent studies suggest that cells may undergo intermediate states during EMT, known as epithelial-mesenchymal plasticity (EMP), which exhibit enhanced aggressiveness and more efficient metastasis. This review aims to summarize and analyze current knowledge on SMAD4 loss in PDAC patients and investigate its potential role in EMP, in order to better understand its function in PDAC carcinogenesis.
Review
Pharmacology & Pharmacy
Sara Lovisa
Summary: EMT, a process crucial in wound healing, fibrosis, and cancer, has gained significant attention from researchers since its discovery in the seventies. Despite advances in understanding its functional role, targeting EMT in fibrotic diseases remains a challenge at an early stage of development.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Tao Fan, Shuofeng Li, Chu Xiao, He Tian, Yujia Zheng, Yu Liu, Chunxiang Li, Jie He
Summary: CCL20 plays a role in promoting lung adenocarcinoma progression, with high expression associated with poor prognosis and activation of EMT, inflammatory response, and TNF pathway. Knockdown of CCL20 inhibits EMT process and cell proliferation in lung adenocarcinoma. Low CCL20 expression improves response to anti-PD-L1 therapy.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2022)
Review
Oncology
Nishant Thakur, Muhammad Joan Ailia, Yosep Chong, Ok Ran Shin, Kwangil Yim
Summary: This study evaluated the prognostic significance, clinicopathological value, and relationship with epithelial-mesenchymal transition (EMT) of tumor budding (TB) in lung cancer. The results showed that high-grade TB was significantly associated with poor overall survival (OS) and disease-free survival (DFS), as well as clinicopathological characteristics and EMT markers.
FRONTIERS IN ONCOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Joanna Kozak, Alicja Forma, Marcin Czeczelewski, Pawel Kozyra, Elzbieta Sitarz, Elzbieta Radzikowska-Buchner, Monika Sitarz, Jacek Baj
Summary: Epithelial-mesenchymal transition (EMT) is a key process in the development of gastric cancer, affecting patient outcomes. There is an urgent need for research on pharmacological agents targeting EMT to prevent progression and potential metastasis of gastric cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Article
Immunology
Sarthak Sahoo, Sonali Priyadarshini Nayak, Kishore Hari, Prithu Purkait, Susmita Mandal, Akash Kishore, Herbert Levine, Mohit Kumar Jolly
Summary: Recent research shows that cells with hybrid epithelial/mesenchymal characteristics can have high levels of PD-L1, important for immune evasion, without needing to fully undergo epithelial-mesenchymal transition. This cellular state in breast cancer is associated with resistance to anti-estrogen therapy.
FRONTIERS IN IMMUNOLOGY
(2021)
Review
Biochemistry & Molecular Biology
Anastasios Goulioumis, Kostis Gyftopoulos
Summary: Epithelial-to-mesenchymal transition (EMT) is a molecular phenomenon that occurs in epithelial neoplasms, such as laryngeal carcinoma. EMT leads to the loss of epithelial traits and acquisition of mesenchymal traits by tumor cells, enhancing their migratory capacity. EMT is mediated by complex molecular pathways and involves various changes, including loss of adhesion, cytoskeleton remodeling, evasion of apoptosis and immune surveillance, upregulation of metalloproteinases, etc. Partial EMT models have been accepted to explain the cell plasticity associated with invasion and metastasis of tumors.
Article
Pathology
Valentina Angerilli, Francesca Galuppini, Gianmaria Pennelli, Giuseppe Nicolo' Fanelli, Emanuele S. G. d'Amore, Mauro Michelotto, Pierluigi Pilati, Gaya Spolverato, Salvatore Pucciarelli, Marco Scarpa, Fabio Farinati, Edoardo Savarino, Stefano Realdon, Sara Lonardi, Francesca Bergamo, Fotios Loupakis, Angelo Paolo Dei Tos, Alessandro Vanoli, Matteo Fassan
Summary: The study presented an unusual case of EBV-associated gastric dysplasia, suggesting a possible early direct role of EBV in gastric carcinogenesis. It also indicated that non-conventional EBV-associated dysplasia may represent a novel histopathological entity in the context of gastric dysplasia.
Article
Pathology
Giovanni Zarrilli, Valentina Angerilli, Rocco Cappellesso, Francesca Galuppini, Gianmaria Pennelli, Fabio Farinati, Lorenzo Nicole, Edoardo Savarino, Stefano Realdon, Gaia Griguolo, Michele Bottosso, Maria Vittoria Dieci, Valentina Guarneri, Angelo Paolo Dei Tos, Marcello Lo Mele, Matteo Fassan
Summary: The metastatic spread of breast carcinoma to the stomach is rare and often poses a diagnostic challenge. This study retrospectively identified 23 cases of gastric metastases from breast cancer and analyzed their histotype, localization, appearance, and architecture. The findings suggest that immunohistochemistry, specifically a panel of cytokeratins 7 and 20, Estrogen and Progesteron Receptors, can significantly improve diagnostic accuracy.
PATHOLOGY RESEARCH AND PRACTICE
(2022)
Article
Endocrinology & Metabolism
Francesca Galuppini, Simona Censi, Isabella Merante Boschin, Matteo Fassan, Marta Sbaraglia, Nicola Valeri, Jens Claus Hahne, Loris Bertazza, Giada Munari, Marco Galasso, Luciano Cascione, Susi Barollo, Massimo Rugge, Federica Vianello, Angelo Paolo Dei Tos, Caterina Mian, Gianmaria Pennelli
Summary: This study analyzed the miRNA expression profiles of different histological variants and mutations in papillary thyroid carcinoma (PTC) samples and found that miRNA signatures were associated with specific histotypes and BRAF mutations.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Health Care Sciences & Services
Matteo Brunelli, Guido Martignoni, Giorgio Malpeli, Alessandro Volpe, Luca Cima, Maria Rosaria Raspollini, Mattia Barbareschi, Alessandro Tafuri, Giulia Masi, Luisa Barzon, Serena Ammendola, Manuela Villanova, Maria Angela Cerruto, Michele Milella, Sebastiano Buti, Melissa Bersanelli, Giuseppe Fornarini, Sara Elena Rebuzzi, Valerio Gaetano Vellone, Gabriele Gaggero, Giuseppe Procopio, Elena Verzoni, Sergio Bracarda, Martina Fanelli, Roberto Sabbatini, Rodolfo Passalacqua, Bruno Perrucci, Maria Olga Giganti, Maddalena Donini, Stefano Panni, Marcello Tucci, Veronica Prati, Cinzia Ortega, Anna Calio, Albino Eccher, Filippo Alongi, Giovanni Pappagallo, Roberto Iacovelli, Alessandra Mosca, Paolo Umari, Ilaria Montagnani, Stefano Gobbo, Francesco Atzori, Enrico Munari, Marco Maruzzo, Umberto Basso, Francesco Pierconti, Carlo Patriarca, Piergiuseppe Colombo, Alberto Lapini, Giario Conti, Roberto Salvioni, Enrico Bollito, Andrea Cossarizza, Francesco Massari, Mimma Rizzo, Renato Franco, Federica Zito-Marino, Yoseba Aberasturi Plata, Francesca Galuppini, Marta Sbaraglia, Matteo Fassan, Angelo Paolo Dei Tos, Maurizio Colecchia, Holger Moch, Maurizio Scaltriti, Camillo Porta, Brett Delahunt, Gianluca Giannarini, Roberto Bortolus, Pasquale Rescigno, Giuseppe Luigi Banna, Alessio Signori, Miguel Angel Llaja Obispo, Roberto Perris, Alessandro Antonelli
Summary: This study aims to overcome intratumoral heterogeneity in clear cell renal cell carcinoma (clearRCC). By using a multisite 3D fusion sampling method, heterogeneity in angiogenic and immune markers was observed. Additionally, this method can uncover new morphological features and provide more accurate pathological assessment.
JOURNAL OF PERSONALIZED MEDICINE
(2022)
Review
Gastroenterology & Hepatology
Rachele Biancotti, Carlo Alberto Dal Pozzo, Paola Parente, Gianluca Businello, Valentina Angerilli, Stefano Realdon, Edoardo Vincenzo Savarino, Fabio Farinati, Anna Caterina Milanetto, Claudio Pasquali, Roberto Vettor, Federica Grillo, Gianmaria Pennelli, Claudio Luchini, Luca Mastracci, Alessandro Vanoli, Massimo Milione, Francesca Galuppini, Matteo Fassan
Summary: This review focuses on the precursor lesions of neuroendocrine tumors in the gastro-entero-pancreatic tract. It distinguishes well-recognized pathophysiological and morphological entities with eventual molecular correlations from those in which the preneoplastic changes are still unclear. The aim of the paper is to provide a useful tool for future research in understanding the underlying biology and early development of gastro-entero-pancreatic neuroendocrine tumors.
DIGESTIVE DISEASES
(2023)
Article
Pathology
Valentina Angerilli, Gianmaria Pennelli, Francesca Galuppini, Stefano Realdon, Alberto Fantin, Edoardo Savarino, Fabio Farinati, Luca Mastracci, Claudio Luchini, Matteo Fassan
Summary: The study on gastroesophageal dysplastic lesions revealed heterogeneity in TCGA/ACRG classes, with different distribution from cancers and positive associations found between different subtypes.
Article
Oncology
Irene Tizianel, Mario Caccese, Francesca Torresan, Giuseppe Lombardi, Laura Evangelista, Filippo Crimi, Matteo Sepulcri, Maurizio Iacobone, Marta Padovan, Francesca Galuppini, Vittorina Zagonel, Carla Scaroni, Filippo Ceccato
Summary: The study found a significant improvement in survival rates for ACC patients after multidisciplinary team evaluation in 2013. Therefore, it is suggested that ACC patients should be referred to a tertiary center from the time of diagnosis in order to promptly apply all available treatments.
Meeting Abstract
Oncology
S. E. Rebuzzi, P. Rescigno, A. Signori, M. Brunelli, F. Galuppini, V. G. Vellone, G. Gaggero, M. Maruzzo, M. Milella, F. Vignani, A. Cavo, U. Basso, F. Catalano, V. Murianni, M. Cremante, A. Damassi, M. A. Llaja Obispo, G. L. Banna, S. Buti, G. Fornarini
ANNALS OF ONCOLOGY
(2022)
Review
Oncology
Pasquale Pisapia, Vincenzo L'Imperio, Francesca Galuppini, Elham Sajjadi, Alessandro Russo, Bruna Cerbelli, Filippo Fraggetta, Giulia D'Amati, Giancarlo Troncone, Matteo Fassan, Nicola Fusco, Fabio Pagni, Umberto Malapelle
Summary: Anatomic pathology has undergone significant changes in recent years, with molecular profiling becoming equally important in cancer diagnosis. Modern pathologists must acquire additional knowledge in predictive molecular pathology to bridge the gap between clinicians and molecular biologists, and they play a growing role in the management of cancer patients.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
(2022)
Article
Oncology
Francesca Torresan, Simona Censi, Gianmaria Pennelli, Francesca Galuppini, Caterina Mian, Maurizio Iacobone
Summary: The study demonstrates that prophylactic and early thyroidectomy are safe and effective procedures for RET mutation carriers, achieving definitive cure in most cases. However, there is a risk of long-term recurrence, even in cases with small and localized MTC, emphasizing the importance of early prophylactic surgery to prevent microMTC development.
Review
Oncology
Davide Bimbatti, Nicolo Cavasin, Francesca Galuppini, Alessandro Rago, Gaetano Ramondo, Eleonora Lai, Michele Dionese, Elisa Erbetta, Umberto Basso, Marco Maruzzo
Summary: This article presents a rare case of renal cell carcinoma (RCC) that initially presented with multiple liver and lymph node metastases but no primary renal lesion. The patient achieved an impressive response to treatment with a combination of immune checkpoint inhibitors and tyrosine kinase inhibitors. A multidisciplinary approach and diagnostic strategy are crucial for reaching a definitive diagnosis and selecting the appropriate treatment for mRCC without a primary tumor.
ANTICANCER RESEARCH
(2023)
Article
Oncology
Sara Elena Rebuzzi, Matteo Brunelli, Francesca Galuppini, Valerio Gaetano Vellone, Alessio Signori, Fabio Catalano, Alessandra Damassi, Gabriele Gaggero, Pasquale Rescigno, Marco Maruzzo, Sara Merler, Francesca Vignani, Alessia Cavo, Umberto Basso, Michele Milella, Olimpia Panepinto, Manlio Mencoboni, Marta Sbaraglia, Angelo Paolo Dei Tos, Veronica Murianni, Malvina Cremante, Miguel Angel Llaja Obispo, Michele Maffezzoli, Giuseppe Luigi Banna, Sebastiano Buti, Giuseppe Fornarini
Summary: This study identified differential immunohistochemical patterns in the tumors of patients who responded and did not respond to nivolumab, an immunotherapy. Tumors in responders showed poor presence of CD4+ immune cells, high expression of CD56 on tumor cells, and high expression of phosphorylated mTOR protein. Further investigation with genomic analysis is planned to examine the prognostic role of the tumor microenvironment.
Article
Oncology
Francesca Torresan, Arianna Beber, Donatella Schiavone, Stefania Zovato, Francesca Galuppini, Filippo Crimi, Filippo Ceccato, Maurizio Iacobone
Summary: The study analyzed the long-term outcomes in 170 patients who underwent surgery for pheochromocytoma and sympathetic paraganglioma (PHEO/sPGL). It was found that even apparently benign and sporadic variants had a risk of long-term recurrence, highlighting the importance of lifelong follow-up.
Meeting Abstract
Orthopedics
A. Scanu, R. Luisetto, M. Pavan, C. Guarise, R. Beninatto, C. Giraudo, F. Galuppini, V. Lazzarin, V. Guzzardo, G. Pennelli, D. Galesso, S. Masiero
OSTEOARTHRITIS AND CARTILAGE
(2022)
Article
Endocrinology & Metabolism
Simona Censi, Antonio De Rosa, Francesca Galuppini, Jacopo Manso, Loris Bertazza, Isabella Merante-Boschin, Mario Plebani, Diego Faggian, Gianmaria Pennelli, Susi Barollo, Federica Vianello, Maurizio Iacobone, Caterina Mian
Summary: The study found that in some patients with persistent or recurrent DTC, serum Tg levels were undetectable, and the reasons for this phenomenon remain unknown. However, for low/intermediate-risk patients cured at one-year follow-up, using highly sensitive Tg without neck ultrasounds seems to be an appropriate management strategy.